Conference
Pharmacokinetic (PK) and updated survival data from the Canadian cancer trials group IND226 study of durvalumab +/- tremelimumab in combination with platinum-doublet chemotherapy
Authors
Hao D; Ellis PM; Laurie SA; Juergens RA; Mates M; Bradbury PA; Tsao M; Tehfe M; Kollmannsberger CK; Goffin JR
Volume
30
Publisher
ELSEVIER
Publication Date
October 1, 2019
Name of conference
44th Annual Congress of the European-Society-for-Medical-Oncology (ESMO)
Conference place
SPAIN, Barcelona
Conference start date
September 27, 2019
Conference end date
October 1, 2019
Conference proceedings
ANNALS OF ONCOLOGY
ISSN
0923-7534